Stryker Corporation (SYK)
NYSE • Healthcare
May 20, 2026 at 16:00 UTC
About Stryker Corporation
Stryker Corporation is a medical technology company that develops implants, surgical equipment, and patient care solutions used in hospitals and ambulatory centers. Its focus is practical: help clinicians restore mobility, perform procedures with confidence, and manage recovery under clear protocols. Engineering teams work with surgeons and care staff to refine instruments and workflows so products fit existing routines. Manufacturing and quality systems aim for dependable availability once a therapy is adopted. Education, service, and digital tools support safe use over long lifecycles. The company operates across many regions and clinical settings, but the promise remains the same: devices and systems that integrate cleanly into real care, backed by training and support that keep operating rooms and wards prepared for the next case.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Stryker Corporation's Technical Indicators Summary
SYK presents a mixed, neutral setup: short-term averages sit below the price and intraday VWAP is aligned with the market, suggesting near-term support, while medium- and long-term EMAs remain well above the current level and signal longer-term resistance. Momentum indicators are mixed—RSI modestly positive but MACD is negative—and ADX just under 30 shows a more noticeable trend without clear directional conviction. Volatility is moderate and OBV readings are ambiguous. Technical takeaway: Overall technicals are neutral, reflecting short-term strength set against longer-term resistance.
| Indicator | Value |
|---|---|
RSI (14) | 53.79 |
Stochastic %K (14, 3, 3) | 92.64 |
CCI (20) | 53.90 |
WPR (14) | -2.56 |
Momentum (10) | 25.63 |
MFI | 64.98 |
MACD Level (12, 26) | -5.12 |
Bollinger Bands | $276.82 - $336.29 |
ATR (14) | $8.68 (2.73%) |
ADX (14) | 28.43 |
OBV | -18,501,450 |
VWAP | $317.16 |
Classic Pivot Point | $315.57 |
Fibonacci Pivot Point | $315.57 |
Exponential Moving Averages | $308.03 - $354.00(5 indicators) |
Simple Moving Averages | $302.00 - $324.58(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Into the close, SYK still reflected a gentle 1.18% gap from yesterday, ending the session at 321.49. By the final print, sector returns hovered near -0.12%, reflecting a largely neutral environment. SYK edges on a gentle gap as Atle Fund Management AB boosts its SYK stake, underscoring institutional support in a neutral sector.
Price Change
from $321.42 close
-$0.03
Trading Volume
Below avg (3.1M)
2.4M
vs S&P 500 Today
Outperforming Market
+2.69%
52-Week Position
Lower range
32.7%
Updated: May 20, 2026 at 20:15 UTC
Quote Summary
SYK Headlines
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Quiet Compounders Lead 2025’s Year-End Market Tone
January 1, 2026